Home NDC 0615-1333 Triamterene and Hydrochlorothiazide
Product NDC 0615-1333
11-digit product format 006151333
Labeler code 0615
Product ID 0615-1333_194a19cf-d20f-43f0-b279-e23b8e23f540
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name triamterene and hydrochlorothiazide
Dosage form CAPSULE
Route ORAL
Labeler NCS HealthCare of KY, Inc dba Vangard Labs
Application ANDA074701
Marketing category ANDA
Marketing start 2011-05-04
Marketing end 0000-00-00
Substance HYDROCHLOROTHIAZIDE; TRIAMTERENE
Active strength 25 mg/1; mg/1
Pharmacologic classes Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS],Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC]
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 57 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0615-1333-39 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0615-1333-31 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0615-1333-39 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0615-1333-31 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 0615-1333-39 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 0615-1333-31 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 0615-1333-39 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 0615-1333-31 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 0615-1333-39 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 0615-1333-31 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 0615-1333-39 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 0615-1333-31 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 0615-1333-39 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 0615-1333-31 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 0615-1333-39 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 0615-1333-31 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 0615-1333-39 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 0615-1333-31 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 0615-1333-39 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 0615-1333-31 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 0615-1333-39 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 0615-1333-31 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 0615-1333-39 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 0615-1333-31 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 0615-1333-31 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 0615-1333-39 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 0615-1333-31 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 0615-1333-39 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 0615-1333-31 I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 0615-1333-39 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 0615-1333-31 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 0615-1333-39 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 0615-1333-31 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 0615-1333-39 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 0615-1333-31 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 0615-1333-39 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 0615-1333-31 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 0615-1333-39 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE; TRIAMTERENE 25MG;37.5MG CAPSULE / ORAL 1996-06-07
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 43 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 84e616aacf4f…2026-08-18 06:07:40 2026-07 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL AB 1996-06-07 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL AB 1996-06-07 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL AB 1996-06-07 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL AB 1996-06-07 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL AB 1996-06-07 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL AB 1996-06-07 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL AB 1996-06-07 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL AB 1996-06-07 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL AB 1996-06-07 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL AB 1996-06-07 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL AB 1996-06-07 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL AB 1996-06-07 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL AB 1996-06-07 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A074701-001 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 25MG;37.5MG CAPSULE / ORAL 1996-06-07 f41ea6bd6efb…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT 0J48LPH2TH TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 2 TRIAMTERENE ACTIVE INGREDIENT WS821Z52LQ TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 2 HYDROCHLOROTHIAZIDE ACTIVE MOIETY 0J48LPH2TH TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 2 TRIAMTERENE ACTIVE MOIETY WS821Z52LQ TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 2 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 2 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 2 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 2 FD&C BLUE NO. 2 INACTIVE INGREDIENT L06K8R7DQK TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 2 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 2 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 2 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 2 GELATIN INACTIVE INGREDIENT 2G86QN327L TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 2 POLYETHYLENE GLYCOLS INACTIVE INGREDIENT 3WJQ0SDW1A TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 2 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 2 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 2 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 2 SODIUM BICARBONATE INACTIVE INGREDIENT 8MDF5V39QO TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 2 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 2 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 2